NovelStem International Corp. (NSTM)
2025-06-30 | ||||
|---|---|---|---|---|
| Equity in net income (loss) of equity method investees | 340 | |||
| Provision for income tax | - | |||
| General and administrative expenses | 63,964 | |||
| Total operating expenses | 63,964 | |||
| Administrative fee income | - | |||
| Loss from operations | -63,964 | |||
| Interest expense | 51,319 | |||
| Gain on disposal of equity method investment | 1,171,760 | |||
| Gain on derivative instrument | - | |||
| Relief of indebtedness income | -1,697,024 | |||
| Total other (income) expenses | 2,817,465 | |||
| Income (loss) before income taxes | 2,753,501 | |||
| Income (loss) before equity in net income (loss) of equity method investees | 2,753,501 | |||
| Net income (loss) | 2,753,841 | |||
| Net income loss per share - basic | 0.06 | |||
| Net income loss per share - diluted | 0.06 | |||
| Weighted average number of shares outstanding - basic | 46,881,475 | |||
| Weighted average number of shares outstanding-diluted | 47,765,983 | |||